Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Attal is active.

Publication


Featured researches published by J. Attal.


Frontiers in Behavioral Neuroscience | 2013

Social motor coordination in unaffected relatives of schizophrenia patients: a potential intermediate phenotype.

Jonathan Del-Monte; Delphine Capdevielle; Manuel Varlet; Ludovic Marin; R. C. Schmidt; Robin N. Salesse; Benoît G. Bardy; Jean-Philippe Boulenger; Marie Christine Gély-Nargeot; J. Attal; Stéphane Raffard

Intermediate endophenotypes emerge as an important concept in the study of schizophrenia. Although research on phenotypes mainly investigated cognitive, metabolic or neurophysiological markers so far, some authors also examined the motor behavior anomalies as a potential trait-marker of the disease. However, no research has investigated social motor coordination despite the possible importance of its anomalies in schizophrenia. The aim of this study was thus to determine whether coordination modifications previously demonstrated in schizophrenia are trait-markers that might be associated with the risk for this pathology. Interpersonal motor coordination in 27 unaffected first-degree relatives of schizophrenia patients and 27 healthy controls was assessed using a hand-held pendulum task to examine the presence of interpersonal coordination impairments in individuals at risk for the disorder. Measures of neurologic soft signs, clinical variables and neurocognitive functions were collected to assess the cognitive and clinical correlates of social coordination impairments in at-risk relatives. After controlling for potential confounding variables, unaffected relatives of schizophrenia patients had impaired intentional interpersonal coordination compared to healthy controls while unintentional interpersonal coordination was preserved. More specifically, in intentional coordination, the unaffected relatives of schizophrenia patients exhibited coordination patterns that had greater variability and in which relatives did not lead the coordination. These results show that unaffected relatives of schizophrenia patients, like the patients themselves, also present deficits in intentional interpersonal coordination. For the first time, these results suggest that intentional interpersonal coordination impairments might be a potential motor intermediate endophenotype of schizophrenia opening new perspectives for early diagnosis.


European Eating Disorders Review | 2016

A Lack of Clinical Effect of High-frequency rTMS to Dorsolateral Prefrontal Cortex on Bulimic Symptoms: A Randomised, Double-blind Trial

Isabelle Jaussent; Torrance Sigaud; Stéphane Billard; J. Attal; Maude Seneque; B. Galusca; Frederique Van den Eynde; Catherine Massoubre; Philippe Courtet; Sébastien Guillaume

Studies suggest that stimulation of the left dorsolateral prefrontal cortex (DLPFC) reduces food craving in bulimic patients, but evidence supporting repetitive transcranial magnetic stimulation (rTMS) as a therapeutic tool is lacking. We investigated the safety and therapeutic efficacy of an adjunct high-frequency rTMS programme targeting the left DLPFC. Forty-seven women with bulimia nervosa were randomised to a real or sham stimulation group. The real group underwent 10 rTMS sessions, each consisting of 20 trains of 5 seconds with 55-second intervals between trains, at a frequency of 10 Hz. The main outcome was the number of binge episodes in the 15 days following the end of stimulation. Overall, no significant improvement in bingeing and purging symptoms was noted after the programme. rTMS was well tolerated. This suggests that 10 sessions of high-frequency rTMS to the left DLPFC provide no greater benefit than placebo. Future studies should consider methodological issues as well as alternative targets. Copyright


Psychiatry and Clinical Neurosciences | 2012

Treating patients with schizophrenia deficit with erythropoietin

Guillaume Fond; Alexandra Macgregor; J. Attal; Aurore Larue; Marie Brittner; D. Ducasse; Delphine Capdevielle

This systematic review summarizes and critically appraises the literature on the effect of erythropoietin (EPO) in schizophrenia patients and the pathophysiological mechanisms that may explain the potential of its use in this disease. EPO is mainly known for its regulatory activity in the synthesis of erythrocytes and is frequently used in treatment of chronic anemia. This cytokine, however, has many other properties, some of which may improve the symptoms of psychiatric illness. The review follows the preferred reporting items for systematic reviews and meta‐analysis (PRISMA) statement guidelines. Three databases (Medline, Web of Science, and Cochrane) were searched combining the search terms ‘erythropoietin AND (psychotic disorders OR schizophrenia)’. Seventy‐eight studies were included in qualitative synthesis, a meta‐analytic approach being prohibited. The findings suggest that several EPO cerebral potential properties may be relevant for schizophrenia treatment, such as neurotransmission regulation, neuroprotection, modulation of inflammation, effects on blood–brain barrier permeability, effects on oxidative stress and neurogenesis. Several potentially detrimental side‐effects of EPO therapy, such as increased risk of thrombosis, cancer, increased metabolic rate and mean arterial blood pressure leading to cerebral ischemia could severely limit or halt the use of EPO. Overall, because the available data are inconclusive, further efforts in this field are warranted.


Psychiatry Research-neuroimaging | 2011

Insight is not associated with insensitivity to future consequences in schizophrenia

Stéphane Raffard; Delphine Capdevielle; Marie-Christine Gély-Nargeot; J. Attal; Alexandra Baillard; Jonathan Del-Monte; Nawel Mimoun; Jean-Philippe Boulenger; Sophie Bayard

In this study, we examined the association between insight and decision-making capacity in schizophrenia using the Iowa Gambling Task (IGT). No association was found between insight and IGT scores. Our results suggest that impaired decision-making ability in schizophrenia patients cannot be solely predicted by lack of insight.


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2013

La phobie du sang-injection-accident: spécificités psychophysiologiques et thérapeutiques

D. Ducasse; Delphine Capdevielle; J. Attal; A. Larue; Alexandra Macgregor; Marie Brittner; Guillaume Fond

INTRODUCTION Seventy-five percent of patients with blood-injection-injury phobia (BII-phobia) report a history of fainting in response to phobic stimuli. This specificity may lead to medical conditions remaining undiagnosed and untreated, incurring considerable cost for the individual and society. The psychophysiology of BII-phobia remains poorly understood and the literature on effective treatments has been fairly sparse. Aims of the systematic review: to synthesize the psychophysiology of BII-phobia and to propose a systematic review of the literature on effectiveness of different treatments evaluated in this indication. RESULTS Firstly, the most distinct feature of the psychophysiology of BII-phobia is its culmination in a vasovagal syncope, which has been described as biphasic. The initial phase involves a sympathetic activation as is typically expected from fear responses of the fight-flight type. The second phase is characterized by a parasympathetic activation leading to fainting, which is associated with disgust. Subjects with syncope related to BII-phobia have an underlying autonomic dysregulation predisposing them to neurally mediated syncope, even in the absence of any blood or injury stimulus. Many studies report that BII-phobic individuals have a higher level of disgust sensitivity than individuals without any phobia. Secondly, behavioral psychotherapy techniques such as exposure only, applied relaxation, applied tension, and tension only, have demonstrated efficacy with no significant difference between all these techniques. The disgust induction has not improved effectiveness of exposure. CONCLUSION We have explained the psychophysiology of BII-phobia, the understanding of which is required to study and validate specific techniques, in order to improve the prognosis of this disorder, which is a public health issue.


International Journal of Eating Disorders | 2018

Improving decision-making and cognitive impulse control in bulimia nervosa by rTMS: An ancillary randomized controlled study

Sébastien Guillaume; Isabelle Jaussent; Torrance Sigaud; Stéphane Billard; J. Attal; Maude Seneque; B. Galusca; Sylvain Thiebaut; Catherine Massoubre; Philippe Courtet

OBJECTIVE Impaired decision-making and inhibitory control may be involved in the pathophysiology of psychiatric disorders like bulimia nervosa (BN). Their improvement after neuromodulation may underpin clinical improvement. We assessed the effects of rTMS on these cognitive functions in a sample of women with BN. METHODS Thirty-nine participants (22 in a sham group and 17 in an rTMS group) were assessed before and after 10 high frequency rTMS sessions over the left dorsolateral prefrontal cortex (DLPFC). RESULTS The between-group analyses revealed no differences in the final neuropsychological performances. The within-group analyses showed that inhibitory control improved in both the go/no-go task (p = .03) and the BIS cognitive impulsivity subscale (p = .01) in the rTMS group only. Switches toward good choices on the Iowa gambling task significantly improved in the rTMS group only (p = .002), and understanding of the task contingencies increased between the two assessments, also in the rTMS group only (p = .03). DISCUSSION This preliminary evidence suggests that modulation of left DLPFC might improve two putative cognitive biomarkers of BN.


Psychiatry Research-neuroimaging | 2017

Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image

Catherine Bortolon; Delphine Capdevielle; Rosalie Altman; Alexandra Macgregor; J. Attal; Stéphane Raffard

Self-face recognition is crucial for sense of identity and for maintaining a coherent sense of self. Most of our daily life experiences with the image of our own face happen when we look at ourselves in the mirror. However, to date, mirror self-perception in schizophrenia has received little attention despite evidence that face recognition deficits and self abnormalities have been described in schizophrenia. Thus, this study aims to investigate mirror self-face perception in schizophrenia patients and its correlation with clinical symptoms. Twenty-four schizophrenia patients and twenty-five healthy controls were explicitly requested to describe their image in detail during 2min whilst looking at themselves in a mirror. Then, they were asked to report whether they experienced any self-face recognition difficulties. Results showed that schizophrenia patients reported more feelings of strangeness towards their face compared to healthy controls (U=209.5, p=0.048, r=0.28), but no statistically significant differences were found regarding misidentification (p=0.111) and failures in recognition (p=0.081). Symptoms such as hallucinations, somatic concerns and depression were also associated with self-face perception abnormalities (all p-values>0.05). Feelings of strangeness toward ones own face in schizophrenia might be part of a familiar face perception deficit or a more global self-disturbance, which is characterized by a loss of self-other boundaries and has been associated with abnormal body experiences and first rank symptoms. Regarding this last hypothesis, multisensorial integration might have an impact on the way patients perceive themselves since it has an important role in mirror self-perception.


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2013

[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].

Guillaume Fond; Delphine Capdevielle; Alexandra Macgregor; J. Attal; A. Larue; Marie Brittner; D. Ducasse; Jean-Philippe Boulenger


La Revue du praticien | 2009

[Post-traumatic stress disorder and acute stress disorder].

J. Attal


Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique | 2013

Charisme et leadership : de nouveaux défis pour la psychiatrie

Guillaume Fond; D. Ducasse; J. Attal; A. Larue; Alexandra Macgregor; Marie Brittner; Delphine Capdevielle

Collaboration


Dive into the J. Attal's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Ducasse

University of Montpellier

View shared research outputs
Top Co-Authors

Avatar

Guillaume Fond

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar

Marie Brittner

University of Montpellier

View shared research outputs
Top Co-Authors

Avatar

Jean-Philippe Boulenger

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. Galusca

Jean Monnet University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge